KR100931831B1 - 충치 제거제 - Google Patents
충치 제거제 Download PDFInfo
- Publication number
- KR100931831B1 KR100931831B1 KR1020070112880A KR20070112880A KR100931831B1 KR 100931831 B1 KR100931831 B1 KR 100931831B1 KR 1020070112880 A KR1020070112880 A KR 1020070112880A KR 20070112880 A KR20070112880 A KR 20070112880A KR 100931831 B1 KR100931831 B1 KR 100931831B1
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- amino
- component
- water
- cmc
- Prior art date
Links
- 208000002925 dental caries Diseases 0.000 title claims abstract description 83
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 59
- 150000001413 amino acids Chemical class 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical group 0.000 claims abstract description 4
- 229910052761 rare earth metal Inorganic materials 0.000 claims abstract description 4
- 150000002910 rare earth metals Chemical class 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 142
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 96
- 239000011780 sodium chloride Substances 0.000 claims description 48
- 229940024606 amino acid Drugs 0.000 claims description 44
- 235000001014 amino acid Nutrition 0.000 claims description 44
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 28
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 28
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 27
- 239000004472 Lysine Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical compound OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 18
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 14
- 229960001230 asparagine Drugs 0.000 claims description 14
- 235000009582 asparagine Nutrition 0.000 claims description 14
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 13
- OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical group OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 claims description 10
- HNDVDQJCIGZPNO-UHFFFAOYSA-N Histidine Chemical compound OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 10
- AGPKZVBTJJNPAG-UHFFFAOYSA-N Isoleucine Chemical compound CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 7
- 239000004474 valine Substances 0.000 claims description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 4
- AHLPHDHHMVZTML-UHFFFAOYSA-N Ornithine Chemical compound NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 4
- HOZBSSWDEKVXNO-DKWTVANSSA-N 2-aminobutanedioic acid;(2s)-2-aminobutanedioic acid Chemical group OC(=O)C(N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-DKWTVANSSA-N 0.000 claims description 3
- UJKDYMOBUGTJLZ-DFWYDOINSA-N 2-aminopentanedioic acid;(2s)-2-aminopentanedioic acid Chemical group OC(=O)C(N)CCC(O)=O.OC(=O)[C@@H](N)CCC(O)=O UJKDYMOBUGTJLZ-DFWYDOINSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- CSFFOBGGUBKCFN-UHFFFAOYSA-N 2,4-diamino-2-methylbutanoic acid Chemical compound OC(=O)C(N)(C)CCN CSFFOBGGUBKCFN-UHFFFAOYSA-N 0.000 claims description 2
- LNDPCYHWPSQBCA-UHFFFAOYSA-N 2,5-diamino-2-methylpentanoic acid Chemical compound OC(=O)C(N)(C)CCCN LNDPCYHWPSQBCA-UHFFFAOYSA-N 0.000 claims description 2
- CPUSCHYXEUZMSV-UHFFFAOYSA-N 2,6-diamino-2-methylhexanoic acid Chemical compound OC(=O)C(N)(C)CCCCN CPUSCHYXEUZMSV-UHFFFAOYSA-N 0.000 claims description 2
- DQLDJYFGVBVMIU-UHFFFAOYSA-N 2,7-diamino-2-methylheptanoic acid Chemical compound OC(=O)C(N)(C)CCCCCN DQLDJYFGVBVMIU-UHFFFAOYSA-N 0.000 claims description 2
- NMDDZEVVQDPECF-UHFFFAOYSA-N 2,7-diaminoheptanoic acid Chemical compound NCCCCCC(N)C(O)=O NMDDZEVVQDPECF-UHFFFAOYSA-N 0.000 claims description 2
- CVHUOIYUNHRTNY-UHFFFAOYSA-N 2-amino-2,6-dimethylheptanoic acid Chemical compound CC(C)CCCC(C)(N)C(O)=O CVHUOIYUNHRTNY-UHFFFAOYSA-N 0.000 claims description 2
- CWAYDJFPMMUKOI-UHFFFAOYSA-N 2-amino-2-methylbutanedioic acid Chemical group OC(=O)C(N)(C)CC(O)=O CWAYDJFPMMUKOI-UHFFFAOYSA-N 0.000 claims description 2
- RXHGRYUBJHFKKO-UHFFFAOYSA-N 2-amino-2-methylhexanedioic acid Chemical compound OC(=O)C(N)(C)CCCC(O)=O RXHGRYUBJHFKKO-UHFFFAOYSA-N 0.000 claims description 2
- HDIIAKZNFLPDPT-UHFFFAOYSA-N 2-amino-6-methylheptanoic acid Chemical compound CC(C)CCCC(N)C(O)=O HDIIAKZNFLPDPT-UHFFFAOYSA-N 0.000 claims description 2
- ARSWQPLPYROOBG-UHFFFAOYSA-N 2-azaniumyl-2,4-dimethylpentanoate Chemical compound CC(C)CC(C)(N)C(O)=O ARSWQPLPYROOBG-UHFFFAOYSA-N 0.000 claims description 2
- ILSZSJFABKCVAU-UHFFFAOYSA-N 2-azaniumyl-2,5-dimethylhexanoate Chemical compound CC(C)CCC(C)(N)C(O)=O ILSZSJFABKCVAU-UHFFFAOYSA-N 0.000 claims description 2
- FMUMEWVNYMUECA-UHFFFAOYSA-N 2-azaniumyl-5-methylhexanoate Chemical compound CC(C)CCC(N)C(O)=O FMUMEWVNYMUECA-UHFFFAOYSA-N 0.000 claims description 2
- XRDUNZCLSCKAMY-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;2,4-diamino-4-oxobutanoic acid Chemical compound OC(=O)C(N)CC(N)=O.OC(=O)[C@@H](N)CC(N)=O XRDUNZCLSCKAMY-DKWTVANSSA-N 0.000 claims 1
- BRHPBVXVOVMTIQ-JEDNCBNOSA-N (2s)-2-amino-4-methylpentanoic acid;2-amino-4-methylpentanoic acid Chemical group CC(C)CC(N)C(O)=O.CC(C)C[C@H](N)C(O)=O BRHPBVXVOVMTIQ-JEDNCBNOSA-N 0.000 claims 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 abstract description 55
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract description 53
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract description 53
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract description 53
- 239000005708 Sodium hypochlorite Substances 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 description 52
- 229910019093 NaOCl Inorganic materials 0.000 description 38
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 20
- 235000013922 glutamic acid Nutrition 0.000 description 20
- 239000004220 glutamic acid Substances 0.000 description 20
- 238000011002 quantification Methods 0.000 description 20
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 12
- 235000003704 aspartic acid Nutrition 0.000 description 12
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 8
- 229920003169 water-soluble polymer Polymers 0.000 description 8
- 210000003298 dental enamel Anatomy 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- -1 Arabic Polymers 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 210000004195 gingiva Anatomy 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000004262 dental pulp cavity Anatomy 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000002379 periodontal ligament Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- PYSRRFNXTXNWCD-UHFFFAOYSA-N 3-(2-phenylethenyl)furan-2,5-dione Chemical compound O=C1OC(=O)C(C=CC=2C=CC=CC=2)=C1 PYSRRFNXTXNWCD-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- BIJIDLWVZZPPAY-UHFFFAOYSA-N amino hypochlorite Chemical compound NOCl BIJIDLWVZZPPAY-UHFFFAOYSA-N 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical group ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (3)
- 물에 용해되는 아미노산 X, 아미노산 Y및 아미노산 Z로 이루어진 군으로부터 둘이상 선택되는 아미노산 혼합물;수산화나트륨과 염화나트륨;및카르복실메틸 셀룰로오스(CMC)로 이루어지는 A성분과,상기 A성분과 우식부위 도포직전 혼합되고, M(OX)n(X=Cl, Br이고, n=1일때 M=알칼리 금속이고, n=2일때 M=알칼리희토류금속)의 구조를 갖는 B성분으로 구성되는 것을 특징으로 하되,상기 아미노산 X는 2-aminopentanedioic acid(Glutamic acid) 또는 2-aminosuccinic acid(Aspartic acid)이며;상기 아미노산 Y는 2-amino-4-methylpentanoic acid(Leucine) 또는 2-amino-3-methylbutanoic acid(Valine)이고;상기 아미노산 Z는 2,6-diaminohexanoic acid(Lysine),2,4-diamino-4-oxobutanoic acid(Asparagine) 또는2-amino-3-(1H-imidazol-4-yl)propanoic acid(Histidine)이고;상기 선택된 아미노산은 물 1L에 대하여 각각 30-40mM의 비율로 포함되고;상기 카르복실메틸셀룰로오스(CMC)가 상기한 물에 대하여 1L당 부피비로 1-5%용해되고;상기 B성분은 상기 M(OX)n가 물 1L에 대하여 부피비로 0.5-4%로 첨가된 용해된 성분이며;상기 A성분에 첨가된 물에 대하여, 상기 수산화나트륨은 34~200mM로 포함되고; 상기 염화나트륨은 0.01~1M로 포함되는 것을 특징으로 하는 충치제거제.
- 삭제
- 물에 용해되는 아미노산 X, 아미노산 Y및 아미노산 Z로 이루어진 군으로부터 둘이상 선택되는 아미노산 혼합물;수산화나트륨과 염화나트륨;및카르복실메틸 셀룰로오스(CMC)로 이루어지는 A성분과,상기 A성분과 우식부위 도포직전 혼합되고, M(OX)n(X=Cl, Br이고, n=1일때 M=알칼리 금속이고, n=2일때 M=알칼리희토류금속)의 구조를 갖는 B성분으로 구성되는 것을 특징으로 하되,상기 아미노산 X는 2-aminopentanedioic acid(Glutamic acid), 2-aminosuccinic acid(Aspartic acid), L-2-Aminoadipic acid, 2-aminohexanedioic acid, 2-amino-2-methylsuccinic acid, 2-amino-2-methylpentaedioic acid 또는 2-amino-2-methylhexanedioic acid이고;상기 아미노산 Y는 2-amino-4-methylpentanoic acid(Leucine), 2-amino-3-methylbutanoic acid(Valine), 2-amino-3-methylpentanoic acid(Isoleucine), 2-amino-5-methylhexanoic acid, 2-amino-6-methylheptanoic acid, 2-amino-2,5-dimethylhexanoic acid, 2-amino-2,4-dimethylpentanoic acid 또는 2-amino-2,6-dimethylheptanoic acid 이며;상기 아미노산 Z는 2,6-diaminohexanoic acid(Lysine), 2,4-diamino-4-oxobutanoic acid(Asparagine), 2,4-diaminobutanoic acid, 2,5-diaminopentanoic acid, 2,7-diaminoheptanoic acid, 2,4-diamino-2-methylbutanoic acid, 2,5-diamino-2-methylpentanoic acid, 2,6-diamino-2-methylhexanoic acid, 2,7-diamino-2-methylheptanoic acid 또는 2-amino-3-(1H-imidazol-4-yl)propanoic acid(Histidine)이고;상기 선택된 아미노산은 물 1L에 대하여 각각 30-40mM의 비율로 포함되고;상기 카르복실메틸셀룰로오스(CMC)가 상기한 물에 대하여 1L당 부피비로 1-5%용해되고;상기 B성분은 상기 M(OX)n가 물 1L에 대하여 부피비로 0.5-4%로 첨가된 용해된 성분이며;상기 A성분에 첨가된 물에 대하여, 상기 수산화나트륨은 34~200mM로 포함되고; 상기 염화나트륨은 0.01~1M로 포함되는 것을 특징으로 하는 충치제거제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070112880A KR100931831B1 (ko) | 2007-11-06 | 2007-11-06 | 충치 제거제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070112880A KR100931831B1 (ko) | 2007-11-06 | 2007-11-06 | 충치 제거제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090046629A KR20090046629A (ko) | 2009-05-11 |
KR100931831B1 true KR100931831B1 (ko) | 2009-12-15 |
Family
ID=40856466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070112880A KR100931831B1 (ko) | 2007-11-06 | 2007-11-06 | 충치 제거제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100931831B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101228558B1 (ko) | 2011-03-08 | 2013-02-05 | (주)메디클러스 | 겔타입의 근관세척제 및 그 제조방법 |
KR101515399B1 (ko) * | 2013-11-21 | 2015-04-29 | 연세대학교 산학협력단 | 충치 치료제 조성물 및 이의 제조 방법 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2673473C2 (ru) * | 2013-12-27 | 2018-11-27 | Колгейт-Палмолив Компани | Пребиотические композиции для ухода за полостью рта, содержащие карбоновые кислоты |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989005135A1 (en) | 1987-12-01 | 1989-06-15 | C.Hedward.Medi-Team Ab | Preparation for dental treatment and method for production of the preparation |
WO1998020838A1 (en) | 1996-11-14 | 1998-05-22 | Medi Team Dentalutveckling i Göteborg AB | Preparation for dental treatment |
WO1999034765A1 (en) | 1998-01-09 | 1999-07-15 | Mediteam Dentalutveckling I Göteborg Ab | Preparation for dental treatment |
-
2007
- 2007-11-06 KR KR1020070112880A patent/KR100931831B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989005135A1 (en) | 1987-12-01 | 1989-06-15 | C.Hedward.Medi-Team Ab | Preparation for dental treatment and method for production of the preparation |
WO1998020838A1 (en) | 1996-11-14 | 1998-05-22 | Medi Team Dentalutveckling i Göteborg AB | Preparation for dental treatment |
WO1999034765A1 (en) | 1998-01-09 | 1999-07-15 | Mediteam Dentalutveckling I Göteborg Ab | Preparation for dental treatment |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101228558B1 (ko) | 2011-03-08 | 2013-02-05 | (주)메디클러스 | 겔타입의 근관세척제 및 그 제조방법 |
KR101515399B1 (ko) * | 2013-11-21 | 2015-04-29 | 연세대학교 산학협력단 | 충치 치료제 조성물 및 이의 제조 방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20090046629A (ko) | 2009-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0938282B1 (en) | Preparation for dental treatment | |
CN1368043A (zh) | 对牙釉质无害的牙齿漂白液及其使用方法 | |
JP6751027B2 (ja) | 非晶質リン酸カルシウムを供給する口腔ケア処方システム | |
EP1258239A1 (de) | Chemisch aushärtendes Dental-Bleachingmaterial | |
ITFI980051A1 (it) | Composizione ad uso odontoiatrico per la desensibilizzazione della dentina esposta | |
Maalouf et al. | Removal efficiency of calcium hydroxide dressing from the root canal without chemically active adjuvant | |
KR100931831B1 (ko) | 충치 제거제 | |
CN1368035A (zh) | 对牙釉质无害的牙齿漂白液及其使用方法 | |
CN1368042A (zh) | 对牙釉质无害的牙齿漂白液及其使用方法 | |
US6403060B1 (en) | Preparation for dental treatment | |
RU2674145C1 (ru) | Отбеливающий гель | |
HAN et al. | Study of the fluoridated adhesive resin cement fluoride release, fluoride uptake and acid resistance of tooth structures | |
JP2002145746A (ja) | 歯牙漂白剤 | |
Hajizadeh et al. | Effect of different conditioning protocols on the adhesion of a glass ionomer cement to dentin | |
Donfrancesco et al. | Analysis of stability in time of marginal adaptation of endosequence root repair material on biological samples | |
US6409994B1 (en) | Preparation for dental treatment | |
JP3157153B2 (ja) | 歯科用処置材 | |
CN101474135A (zh) | 一种水溶性龋齿祛腐凝胶及其制造方法 | |
Mhatre et al. | Chemo-mechanical caries removal system-A brief review | |
KR20080082742A (ko) | 충치 제거제 | |
Alencar et al. | Protocols for mechanical cleaning of the post space on the bond strength between root dentin and cementation system | |
JP2008007439A (ja) | 歯牙漂白剤、歯牙漂白剤の製法及び歯牙漂白用装着体 | |
WO2000042975A1 (en) | Preparation for dental treatment | |
Pascon et al. | Effect of cleansers and irrigation methods on primary root dentin permeability | |
Türkaydın et al. | Influence of different vehicles on the Ph and surface tension of calcium hydroxide pastes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121128 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131007 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140926 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20151002 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180426 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181018 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20191209 Year of fee payment: 11 |